Literature DB >> 8397372

Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B cell lymphoma/leukemia.

P K Ghosh1, J Anderson, N Cohen, K Takeshita, G F Atweh, P Lebowitz.   

Abstract

p18 is a well conserved gene coding for an 18 kDa cytosolic phosphoprotein. Although the function of p18 is unknown, it is suspected of playing a role in regulation of cell proliferation or the proliferation-differentiation switch. Here we have found p18 mRNA expression highest in testis, brain, thymus and a multipotent hematopoietic stem cell line and lowest in liver. p18 was also expressed vigorously in all but one of 85 diverse tumor cell lines and primary human malignant specimens examined. In five primary tumors, expression was substantially elevated with respect to expression in contiguous normal tissue. Expression in chronic phase chronic myelogenous leukemia cells was far greater than in normal blood cells and increased with progression of disease. In liver material, the highest level of p18 was found in a primary hepatoblastoma, a stem cell tumor, whereas a benign adenoma demonstrated very low level expression. Cells from a cleaved B cell lymphoma/leukemia failed to express p18 whereas 18 specimens from other B lymphoid malignancies, including a second cleaved cell malignancy, expressed p18 at substantial levels. These data are consistent with p18 playing a role in control of cell proliferation in at least certain tissues. The questions arise if high level p18 expression in certain malignancies may play a primary role in driving cell proliferation or, based on chromosomal localization and inactivation of p18 expression in one lymphoma, if p18 may act as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397372

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray.

Authors:  Zhaoyang Zeng; Yanhong Zhou; Wei Xiong; Xiaomin Luo; Wenling Zhang; Xiaoling Li; Songqing Fan; Li Cao; Ke Tang; Minghua Wu; Guiyuan Li
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-21       Impact factor: 4.553

2.  Gene expression in Barrett's esophagus and reflux esophagitis induced by gastroduodenoesophageal reflux in rats.

Authors:  Peng Cheng; Jun Gong; Tao Wang; Chen Jie; Gui-Sheng Liu; Ru Zhang
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

3.  Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma.

Authors:  Han-Ping Hsu; Chien-Feng Li; Sung-Wei Lee; Wen-Ren Wu; Tzu-Ju Chen; Kwang-Yu Chang; Shih-Shin Liang; Chia-Jung Tsai; Yow-Ling Shiue
Journal:  Tumour Biol       Date:  2013-11-12

4.  A synergistic relationship between three regions of stathmin family proteins is required for the formation of a stable complex with tubulin.

Authors:  Isabelle Jourdain; Sylvie Lachkar; Elodie Charbaut; Benoit Gigant; Marcel Knossow; André Sobel; Patrick A Curmi
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

5.  Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin.

Authors:  S J Mistry; H C Li; G F Atweh
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

6.  Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.

Authors:  Wang Xi; Wang Rui; Lin Fang; Dong Ke; Gao Ping; Zhang Hui-Zhong
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

7.  Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours.

Authors:  P A Curmi; C Noguès; S Lachkar; N Carelle; M P Gonthier; A Sobel; R Lidereau; I Bièche
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

8.  Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors.

Authors:  G Brattsand
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

9.  Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis.

Authors:  Y Kouzu; K Uzawa; H Koike; K Saito; D Nakashima; M Higo; Y Endo; A Kasamatsu; M Shiiba; H Bukawa; H Yokoe; H Tanzawa
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

10.  Overexpression of the stathmin gene in a subset of human breast cancer.

Authors:  I Bièche; S Lachkar; V Becette; C Cifuentes-Diaz; A Sobel; R Lidereau; P A Curmi
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.